Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07246408 · ClinicalTrials.gov registry record · NA

Intermittent Cottonseed Oil Consumption

A NA study of Overweight and Obesity and Dyslipidemia, sponsored by University of Georgia.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT07246408: Recruiting NA study of Overweight and Obesity and Dyslipidemia, sponsored by University of Georgia.

NCT07246408 is a NA study of Overweight and Obesity and Dyslipidemia that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 75 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07246408, a NA study of Overweight and Obesity and Dyslipidemia, is actively recruiting participants, sponsored by University of Georgia.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporating CSO into the diet is sufficient to improve fasting and postprandial blood lipids and other markers of chronic disease risk in both healthy and at-risk populations. This study aims to examine the impact of intermittent CSO consumption at different doses (consumed three times per week (3x/wk)) on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk. The specific aims are: \*Examine the impact of intermittent CSO consumption (3x/week) at two different doses on fasting and postprandial lipids. \*Examine the impact of intermittent CSO consumption (3x/week) at two different doses on other markers of chronic disease risk. Participants will be asked to: \*Consume provided meal replacement shakes and snacks 3 times per week for 56 days. \*Attend three bi-weekly (every other week) short visits for fasting blood draws, body measurements, and collection of the next two weeks' study materials. \*Attend two longer (5.5h) testing visits, which include eating a standardized breakfast meal and having blood drawn periodically before and after breakfast. Researchers will compare CSO-30, CSO-20, and Control groups (receiving no oil) to see if intermittent CSO consumption imparts the same health benefits as previously shown with daily doses of CSO.

Primary Outcome

The concentration of fasting serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, cholesterol/HDL ratio, and non-HDL cholesterol (mg/dL)

Interventions

  • OTHER Control
  • OTHER CSO-30
  • OTHER CSO-20

Study Locations (1)

Georgia

  • University of Georgia - Athens

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2026-01-16
Est. Completion 2029-05
Phase NA
University of Georgia

59 total trials

What NCT07246408 shows while recruiting

NCT07246408 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (67% lower).

The record links to 3 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT07246408 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT07246408 about?

NCT07246408 is a clinical study titled "Intermittent Cottonseed Oil Consumption". Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporatin...

What is the current status of trial NCT07246408?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2026-01-16. Estimated completion is 2029-05.

What conditions does trial NCT07246408 study?

This clinical trial studies the following conditions: Overweight and Obesity, Dyslipidemia, Nutrition, Healthy.

What interventions are being tested in trial NCT07246408?

The interventions under investigation include: Control (OTHER), CSO-30 (OTHER), CSO-20 (OTHER).

Who is sponsoring clinical trial NCT07246408?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07246408 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07246408's enrollment target sits among peer trials

75 68th of 115 higher than 48 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07246408, the US trial registry maintained by the National Library of Medicine. NCT07246408 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.